Hospital General Universitario Gregorio Marañón-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2022

  1. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

    European Journal of Cancer, Vol. 175, pp. 110-119

2020

  1. Latest progress in molecular biology and treatment in genitourinary tumours

    Clinical and Translational Oncology, Vol. 22, Núm. 12, pp. 2175-2195

2018

  1. Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 392-401

  2. Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017) (Clinical and Translational Oncology, (2018), 20, 1, (57-68), 10.1007/s12094-017-1783-2)

    Clinical and Translational Oncology

  3. Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286

  4. SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 57-68

2016

  1. Quality indicators to assure and improve cancer care in Spain using the delphi technique

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558

  2. Retrospective analysis of metastatic non-clear cell renal carcinoma (NCCRC): the Spanish Grupo Centro Experience

    Annals of Oncology, Vol. 27, pp. vi290

  3. SEOM Clinical Guideline for bone metastases from solid tumours (2016)

    Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1243-1253

2015

  1. Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

    Critical Reviews in Oncology/Hematology, Vol. 96, Núm. 2, pp. 308-318

2012

  1. Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

    Critical Reviews in Oncology/Hematology, Vol. 83, Núm. 3, pp. 341-352

  2. SEOM clinical guidelines for treatment of prostate cancer

    Clinical and Translational Oncology, Vol. 14, Núm. 7, pp. 520-527

  3. Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice

    Clinical and Translational Oncology, Vol. 14, Núm. 7, pp. 499-504

2009

  1. Adjuvant chemotherapy for stages II, III and IV of colon cancer

    Clinical and Translational Oncology, Vol. 11, Núm. 8, pp. 526-533

2007

  1. Update in the management of ovarian and cervical carcinoma

    Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 443-451